{
    "hands_on_practices": [
        {
            "introduction": "Before a drug can exert its effect on the central nervous system, it must cross the formidable blood-brain barrier. This practice explores how fundamental principles of acid-base chemistry dictate a drug's ability to passively diffuse into the brain. By applying the Henderson-Hasselbalch equation, you will learn to calculate the fraction of a drug in its lipid-soluble, unionized form, a critical parameter in predicting its pharmacokinetic behavior and CNS bioavailability .",
            "id": "4933015",
            "problem": "A medicinal chemistry team is evaluating a tertiary amine acetylcholinesterase (AChE) inhibitor candidate intended to increase synaptic acetylcholine (ACh). The compound is a monoprotic tertiary amine whose conjugate acid has dissociation constant characterized by $pK_{a}=8.5$. In plasma and brain interstitial fluid, assume $pH=7.4$. For passive transcellular diffusion across the blood–brain barrier (BBB) into the Central Nervous System (CNS), assume that only the unionized base form crosses membranes to a first approximation, ignore protein binding and active transport, and treat the system as an equilibrium in a homogeneous aqueous phase.\n\nStarting from acid–base equilibrium principles and the Henderson–Hasselbalch relation, derive an expression for the fraction of the drug that is unionized at $pH=7.4$ and $pK_{a}=8.5$, then compute its numerical value. Finally, based on the fraction you compute, state whether passive CNS penetration is expected to be more or less likely than that of an otherwise similar quaternary ammonium analog that is permanently charged, and justify your reasoning qualitatively.\n\nRound your numerical answer for the fraction unionized to four significant figures. Express the fraction as a pure number with no units.",
            "solution": "The problem requires the derivation and calculation of the fraction of a tertiary amine drug that is in its unionized form at physiological $pH$, and a subsequent qualitative comparison of its expected passive transport across the blood–brain barrier (BBB) with that of a permanently charged analog.\n\nThe problem is first validated.\n\n**Step 1: Extract Givens**\n- Drug type: Monoprotic tertiary amine.\n- Dissociation constant of the conjugate acid: $pK_{a}=8.5$.\n- Physiological pH: $pH=7.4$.\n- Transport mechanism across BBB: Passive transcellular diffusion.\n- Transported species: Only the unionized base form.\n- Assumptions: Equilibrium in a homogeneous aqueous phase, ignore protein binding, ignore active transport.\n- Required outputs:\n    1. An expression for the fraction unionized.\n    2. The numerical value of this fraction, rounded to four significant figures.\n    3. A qualitative comparison of CNS penetration relative to a quaternary ammonium analog.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is scientifically grounded, well-posed, and objective. It is based on the fundamental principles of acid-base chemistry (the Henderson-Hasselbalch equation) and their direct application to pharmacokinetics, a core concept in medicinal chemistry and pharmacology. The given values for $pK_a$ and $pH$ are realistic. The assumptions provided are standard for simplifying such problems to a tractable form. The problem statement is complete, consistent, and unambiguous.\n\n**Step 3: Verdict and Action**\nThe problem is deemed valid. A full solution will be provided.\n\nA tertiary amine, denoted as $B$, is a base that can accept a proton ($H^+$) to form its conjugate acid, the protonated amine $BH^+$. The equilibrium for the dissociation of the conjugate acid is:\n$$BH^+ \\rightleftharpoons B + H^+$$\nIn this equilibrium, $BH^+$ is the ionized (protonated) form of the drug, and $B$ is the unionized (free base) form. The problem states that the $pK_a$ for this dissociation is $8.5$.\n\nThe relationship between $pH$, $pK_a$, and the concentrations of the conjugate acid-base pair is described by the Henderson-Hasselbalch equation:\n$$pH = pK_a + \\log_{10}\\left(\\frac{[B]}{[BH^+]}\\right)$$\nwhere $[B]$ is the molar concentration of the unionized base and $[BH^+]$ is the molar concentration of the ionized conjugate acid.\n\nWe are asked to derive an expression for the fraction of the drug that is unionized, which we will denote as $f_B$. This fraction is defined as the concentration of the unionized form divided by the total concentration of the drug in all forms:\n$$f_B = \\frac{[B]}{[B] + [BH^+]}$$\nTo express $f_B$ in terms of $pH$ and $pK_a$, we first rearrange the Henderson-Hasselbalch equation to solve for the ratio of the concentrations:\n$$\\log_{10}\\left(\\frac{[B]}{[BH^+]}\\right) = pH - pK_a$$\nExponentiating both sides with base $10$ gives:\n$$\\frac{[B]}{[BH^+]} = 10^{(pH - pK_a)}$$\nFrom this ratio, we can express $[BH^+]$ in terms of $[B]$:\n$$[BH^+] = [B] \\cdot 10^{-(pH - pK_a)} = [B] \\cdot 10^{(pK_a - pH)}$$\nNow, substitute this expression for $[BH^+]$ into the equation for the fraction $f_B$:\n$$f_B = \\frac{[B]}{[B] + [B] \\cdot 10^{(pK_a - pH)}}$$\nBy factoring out $[B]$ from the denominator, we obtain the final expression:\n$$f_B = \\frac{[B]}{[B](1 + 10^{(pK_a - pH)})} = \\frac{1}{1 + 10^{(pK_a - pH)}}$$\nThis is the derived expression for the fraction of the drug that is unionized.\n\nNext, we compute the numerical value of this fraction using the provided data: $pH = 7.4$ and $pK_a = 8.5$.\nFirst, calculate the exponent:\n$$pK_a - pH = 8.5 - 7.4 = 1.1$$\nSubstitute this value into the expression for $f_B$:\n$$f_B = \\frac{1}{1 + 10^{1.1}}$$\nCalculating the value of $10^{1.1}$:\n$$10^{1.1} \\approx 12.589254$$\nNow, we can calculate $f_B$:\n$$f_B = \\frac{1}{1 + 12.589254} = \\frac{1}{13.589254} \\approx 0.073587$$\nRounding this numerical value to four significant figures as requested gives:\n$$f_B \\approx 0.07359$$\nThis means that at a $pH$ of $7.4$, approximately $7.359\\%$ of the tertiary amine inhibitor exists in its unionized, free base form.\n\nFinally, we compare the passive CNS penetration of this tertiary amine with that of a quaternary ammonium analog.\nPassive transcellular diffusion across the lipophilic BBB is contingent on the molecule being uncharged and sufficiently lipid-soluble. The problem explicitly states that only the unionized form crosses the membrane.\n\nFor the tertiary amine, we calculated a non-zero fraction of the unionized form ($f_B \\approx 0.07359$). Although this fraction is small, the equilibrium between the ionized and unionized forms is dynamic. As the unionized molecules cross the BBB, Le Châtelier's principle dictates that the equilibrium will shift to replenish the unionized form from the ionized pool, thus enabling continuous, albeit potentially slow, transport into the CNS.\n\nA quaternary ammonium analog has a structure of the type $R_4N^+$, where the nitrogen atom is bonded to four carbon atoms and bears a permanent positive charge. This charge cannot be neutralized by the gain or loss of a proton under any physiological $pH$ conditions. Consequently, a quaternary ammonium compound is $100\\%$ ionized at all times. The fraction of its unionized form is effectively zero.\n\nTherefore, because the tertiary amine possesses a non-zero fraction of the membrane-permeable unionized species while the quaternary ammonium analog does not, passive CNS penetration is expected to be **more likely** for the tertiary amine inhibitor. The quaternary ammonium analog would be effectively barred from entering the CNS via passive diffusion due to its permanent charge, making it a peripherally-restricted agent.",
            "answer": "$$\\boxed{0.07359}$$"
        },
        {
            "introduction": "Once a drug reaches its target, such as the enzyme acetylcholinesterase, we need to quantify its inhibitory power. This exercise guides you through the application of Michaelis-Menten kinetics to a scenario of competitive inhibition. You will derive a crucial relationship to determine the remaining enzyme activity in the presence of an inhibitor, providing a quantitative measure of the drug's efficacy at the molecular level .",
            "id": "4932938",
            "problem": "Acetylcholinesterase (AChE) hydrolyzes acetylcholine (ACh) and is subject to reversible competitive inhibition by certain acetylcholinesterase inhibitors used clinically. Consider a preparation of AChE obeying Michaelis–Menten (MM) kinetics at steady state. The inhibitor binds only to the free enzyme (not to the enzyme–substrate complex), with an inhibition constant $K_{i}$ defined by the equilibrium $E + I \\rightleftharpoons EI$ as $K_{i} = \\frac{[E][I]}{[EI]}$. The substrate concentration is set to $[S] = K_{m}$, where $K_{m}$ is the Michaelis constant for ACh hydrolysis, and the enzyme turnover number and total enzyme concentration define $V_{\\max} = k_{\\text{cat}}[E_{t}]$. Using the MM framework and the competitive binding scheme, derive from first principles an expression for the fraction of catalytic activity remaining under inhibition, $\\frac{v_{i}}{v_{0}}$, where $v_{i}$ is the initial rate in the presence of inhibitor and $v_{0}$ is the initial rate in its absence, both measured at $[S] = K_{m}$. Then evaluate this fraction for an inhibitor with $K_{i} = 20\\,\\mathrm{nM}$ at $[I] = 50\\,\\mathrm{nM}$. Express your final answer as a single real number, either as a simplified fraction or as a decimal, with no units.",
            "solution": "The appropriate fundamental base is the Michaelis–Menten (MM) framework for enzyme kinetics together with the competitive inhibition binding equilibria. For an enzyme $E$ acting on substrate $S$ to form $ES$ and product $P$, the MM rate law in the absence of inhibitor is\n$$\nv_{0} = \\frac{V_{\\max}[S]}{K_{m} + [S]},\n$$\nwhere $V_{\\max} = k_{\\text{cat}}[E_{t}]$ and $K_{m}$ is the Michaelis constant.\n\nUnder reversible competitive inhibition, the inhibitor $I$ binds only to free enzyme $E$ with the equilibrium $E + I \\rightleftharpoons EI$ and inhibition constant\n$$\nK_{i} = \\frac{[E][I]}{[EI]}.\n$$\nThe total enzyme concentration is\n$$\n[E_{t}] = [E] + [ES] + [EI].\n$$\nAssuming the quasi-steady-state approximation for $[ES]$ and rapid equilibrium for inhibitor binding, we express $[ES]$ and $[EI]$ in terms of $[E]$:\n- For substrate binding,\n$$\n[ES] = \\frac{[E][S]}{K_{m}}.\n$$\n- For inhibitor binding,\n$$\n[EI] = \\frac{[E][I]}{K_{i}}.\n$$\nTherefore,\n$$\n[E_{t}] = [E] + \\frac{[E][S]}{K_{m}} + \\frac{[E][I]}{K_{i}} = [E]\\left(1 + \\frac{[S]}{K_{m}} + \\frac{[I]}{K_{i}}\\right).\n$$\nSolving for $[E]$ yields\n$$\n[E] = \\frac{[E_{t}]}{1 + \\frac{[S]}{K_{m}} + \\frac{[I]}{K_{i}}}.\n$$\nThen\n$$\n[ES] = \\frac{[E][S]}{K_{m}} = \\frac{[E_{t}][S]/K_{m}}{1 + \\frac{[S]}{K_{m}} + \\frac{[I]}{K_{i}}}.\n$$\nThe velocity in the presence of inhibitor is thus\n$$\nv_{i} = k_{\\text{cat}}[ES] = k_{\\text{cat}}[E_{t}] \\frac{[S]/K_{m}}{1 + \\frac{[S]}{K_{m}} + \\frac{[I]}{K_{i}}} = V_{\\max} \\frac{[S]}{K_{m}\\left(1 + \\frac{[I]}{K_{i}}\\right) + [S]}.\n$$\nThis is the standard competitive inhibition rate law derived from the binding equilibria.\n\nWe seek the fraction of activity remaining $\\frac{v_{i}}{v_{0}}$ at $[S] = K_{m}$. First compute $v_{0}$ at $[S] = K_{m}$:\n$$\nv_{0} = \\frac{V_{\\max}K_{m}}{K_{m} + K_{m}} = \\frac{V_{\\max}}{2}.\n$$\nNext compute $v_{i}$ at $[S] = K_{m}$:\n$$\nv_{i} = \\frac{V_{\\max}K_{m}}{K_{m}\\left(1 + \\frac{[I]}{K_{i}}\\right) + K_{m}} = \\frac{V_{\\max}}{2 + \\frac{[I]}{K_{i}}}.\n$$\nTherefore,\n$$\n\\frac{v_{i}}{v_{0}} = \\frac{\\frac{V_{\\max}}{2 + \\frac{[I]}{K_{i}}}}{\\frac{V_{\\max}}{2}} = \\frac{2}{2 + \\frac{[I]}{K_{i}}}.\n$$\nNow evaluate with $K_{i} = 20\\,\\mathrm{nM}$ and $[I] = 50\\,\\mathrm{nM}$:\n$$\n\\frac{[I]}{K_{i}} = \\frac{50\\,\\mathrm{nM}}{20\\,\\mathrm{nM}} = 2.5,\n$$\nhence\n$$\n\\frac{v_{i}}{v_{0}} = \\frac{2}{2 + 2.5} = \\frac{2}{4.5} = \\frac{4}{9}.\n$$\nThis fraction is dimensionless and can be left as the reduced fraction $\\frac{4}{9}$ or written as the decimal $0.\\overline{4}$.",
            "answer": "$$\\boxed{\\frac{4}{9}}$$"
        }
    ]
}